How long do you continue temozolomide in a patient receiving capecitabine/temozolomide for well-differentiated neuroendocrine tumor?
Do you drop or adjust the temozolomide at any point, or rather continue to progression as long as temozolomide is well tolerated?
Community PollStarted
How long do you continue temozolomide in a patient receiving capecitabine/temozolomide for well-differentiated neuroendocrine tumor?
38 physicians have voted
Join Mednetto vote and see how they answered.
1 Answer
Mednet MemberInvited Expert
Medical Oncology · Mayo Clinic
Answered on
The true answer is that we do not know. There is no question the CAPTEM combo is effective and the highest quality data comes from ECOG E2211 which was just updated at this year's ASCO. In that trial, patients received up to 13 cycles.
In the past, there was the temptation to continue CAPTEM as long...
Join for free or sign in to see the full answer